Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose S-ketamine for prevention of chronic pain after thoracoscopic lung lesion resection
ChiCTR2100042140Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Persistent postsurgical pain (PPSP) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Incidence and severity of chronic pain. Started Feb 2021; status: completed.
02
Drugs
esketamine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ChiCTR2100042140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042140.